Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1979 Sep;64(3):842–849. doi: 10.1172/JCI109532

Comparison of spontaneous and experimentally induced canine prostatic hyperplasia.

D P DeKlerk, D S Coffey, L L Ewing, I R McDermott, W G Reiner, C H Robinson, W W Scott, J D Strandberg, P Talalay, P C Walsh, L G Wheaton, B R Zirkin
PMCID: PMC372190  PMID: 89121

Abstract

Spontaneous prostatic hyperplasia in the beagle appears to progress with age from a glandular to a cystic histological appearance. Prostatic hyperplasia can be induced in young beagles with intact testes by treatment for 4 mo with either dihydrotestosterone or 5 alpha-androstane-3 alpha, 17 beta-diol, alone, or with either of these steroids in combination with 17 beta-estradiol. In contrast, the induction of prostatic hyperplasia in young castrated beagles, in which the gland had been allowed to involute for 1 mo, requires the administration of both 17 beta-estradiol and either 5 alpha-androstane-3 alpha, 17 beta-diol or dihydrotestosterone. Testosterone and 17 beta-estradiol, either singly or in combination, did not produce the hyperplastic condition in intact or castrated beagles. The experimentally induced prostatic hyperplasia is identical in pathology to the glandular hyperplasia that occurs naturally in the aging dog with intact testes. However, cystic hyperplasia was not produced by any of the treatments tested in young animals.

Full text

PDF
842

Images in this article

844Image
on p.844
844Image
on p.844
845Image
on p.845

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERG O. A. Parenchymatous hypertrophy of the canine prostate gland. Acta Endocrinol (Copenh) 1958 Feb;27(2):140–154. doi: 10.1530/acta.0.0270140. [DOI] [PubMed] [Google Scholar]
  2. Bruchovsky N. Comparison of the metabolites formed in rat prostate following the in vivo administration of seven natural androgens. Endocrinology. 1971 Nov;89(5):1212–1222. doi: 10.1210/endo-89-5-1212. [DOI] [PubMed] [Google Scholar]
  3. Gloyna R. E., Siiteri P. K., Wilson J. D. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog. J Clin Invest. 1970 Sep;49(9):1746–1753. doi: 10.1172/JCI106392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. HUGGINS C., SOMMER J. L. Quantitative studies of prostatic secretion. III. Simultaneous measurement of size and secretion of the canine prostate and the interaction of androgenic and estrogenic substances thereon. J Exp Med. 1953 May;97(5):663–680. doi: 10.1084/jem.97.5.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jacobi G. H., Moore R. J., Wilson J. D. Studies on the mechanism of 3 alpha-androstanediol-induced growth of the dog prostate. Endocrinology. 1978 Jun;102(6):1748–1758. doi: 10.1210/endo-102-6-1748. [DOI] [PubMed] [Google Scholar]
  6. Jacobi G. H., Wilson J. D. The formation of 5alpha-androstane-3alpha, 17beta-diol by dog prostate. Endocrinology. 1976 Aug;99(2):602–610. doi: 10.1210/endo-99-2-602. [DOI] [PubMed] [Google Scholar]
  7. Neri R. O., Monahan M. Effects of a novel nonsteroidal antiandrogen on canine prostatic hyperplasia. Invest Urol. 1972 Sep;10(2):123–130. [PubMed] [Google Scholar]
  8. O'SHEA J. D. Studies on the canine prostate gland. I. Factors influencing its size and weight. J Comp Pathol. 1962 Jul;72:321–331. doi: 10.1016/s0368-1742(62)80037-x. [DOI] [PubMed] [Google Scholar]
  9. Ofner P. Effects and metabolism of hormones in normal and neoplastic prostate tissue. Vitam Horm. 1968;26:237–291. doi: 10.1016/s0083-6729(08)60756-6. [DOI] [PubMed] [Google Scholar]
  10. Pradhan B. K., Chandra K. Morphogenesis of nodular hyperplasia--prostate. J Urol. 1975 Feb;113(2):210–213. doi: 10.1016/s0022-5347(17)59446-x. [DOI] [PubMed] [Google Scholar]
  11. SCOTT W. W., HOPKINS W. J., LUCAS W. M., TESAR C. A research for inhibitors of prostate growth stimulators. J Urol. 1957 Apr;77(4):652–659. doi: 10.1016/S0022-5347(17)66615-1. [DOI] [PubMed] [Google Scholar]
  12. Scott W. W., Coffey D. S. Nonsurgical treatment of human benign prostatic hyperplasia. Vitam Horm. 1975;33:439–465. doi: 10.1016/s0083-6729(08)60969-3. [DOI] [PubMed] [Google Scholar]
  13. Walsh P. C., Wilson J. D. The induction of prostatic hypertrophy in the dog with androstanediol. J Clin Invest. 1976 Apr;57(4):1093–1097. doi: 10.1172/JCI108353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Wilson J. D., Gloyna R. E., Siiteri P. K. Androgen metabolism in the hypertrophic prostate. J Steroid Biochem. 1975 Mar-Apr;6(3-4):443–445. doi: 10.1016/0022-4731(75)90169-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES